SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novartis
NVS 123.86+0.1%Nov 3 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Stan Pruss who wrote (199)4/21/1998 5:28:00 PM
From: Stan Pruss  Read Replies (2) of 296
 
Copy of e-mail answer to my question. "Hello, I have been a passive user of SI; today I tried to register to use it free for one month. When I tried to answer your question, the system wanted to pay. Do you think it's worthwile paying it, since there are other forums which are free?
I have been today on the shareholders meeting of Novartis, since it is close to where I'm living. Among the many products to come, these are very interesting: a contact lens working for one month, a drug promoting the creation of insulin in type II of this disease, and a drug which would be used additionally in any cancer chemotherapy.
I expected the share price to come down, because in June there will be a public vote on some laws against some applications of genetic engineering in Switzerland, where the headquarters are. Irrespective of the outcome and the consequences, it will have some psychological effects on the stock. On the other hand, Roche the competitor on the other side of the Rhine, went up today a little bit. I have started buying heavily into this stock since 93 and still think it is the best value in pharma. Price should go up from 2500 to 3000 Francs (+20%) within about one year. Hans Grob, Reichenbachstr. 69, CH-3000 Bern 4
e-mail: hgrob@swissonline.ch
Tel. 031 301 76 07 / 061 971 14 42"

Danke Sehr for your response Herr Grob. If you are seriously interested in stocks, I believe SI is worth the fee. If you do your own research and use a discount broker, you can consider this paying for research and see how much you save in a year. Stan
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext